DATE : 2023-05-02
ATTENDEES : PERSON175, PERSON176, PERSON177, PERSON178, PERSON179, PERSON180, PERSON181, PERSON182, PERSON184, PERSON185, PERSON186, PERSON187, PERSON188, PERSON189, PERSON190, PERSON191, PERSON192, PERSON193, PERSON194, PERSON195, PERSON987, PERSON988, PERSON989, PERSON990


SUMMARY
- The oral question to the Council on joint programming of research to combat neurodegenerative diseases is B7-0218/2009.
- The author, Herbert Reul, is running late and may be given the floor at the end.
- In Europe, there are more than seven million people suffering from Alzheimer's disease.
- The figure is estimated to double over the next 20 years.
- The European Parliament gives high priority to the fight against Alzheimer's disease.
- The Presidency will try to ensure Parliament's views are incorporated into the conclusions that are to be adopted when the Competitiveness Council meets on 3 December this year.
- The Council shares the Member's view that a common approach should be chosen to adopt these initiatives under the research heading.
- The Swedish Presidency wants to adopt in December the conclusions regarding the measures to combat neurodegenerative diseases without waiting for Parliament's view on this issue.
- Parliament's position is vital to take into account when drafting the Council's conclusions.
- Parliament must be involved in all initiatives relating to future joint programming in the field of research.
- PERSON179 would have preferred Parliament to have been more directly involved in the pilot project.
- The Group of the United European Left - Nordic Green Left has tabled a motion for the research results to be made publicly available.
- There is a problem with regard to European patents.
- PERSON181 should have been rapporteur on the dossier, but he was instead an adviser.
- He hopes the Council will take on board the ideas in the resolutions that they are going to vote on tomorrow.
- PERSON182 supports the political issue of joint programming of research on neurodegenerative diseases.
- There are 16,000 people suffering from dementia in PERSON184's constituency of Northern Ireland.
- PERSON185 welcomes the initiatives and the actions undertaken at European level to combat neurodegenerative diseases and Alzheimer's disease.
- PERSON186 is concerned about the implementation of the joint programming tool in terms of bureaucratic complexity and delays in administrative procedures.
- Parliament has a significant role to play in how research in neurodegenerative diseases will be done.
- Parliament and the Council are discussing the issue of the welfare of animals used in scientific experimentation.
- The European Union unites 27 Member States and not all states are equally able to offer assistance to Alzheimer's sufferers.
- The European Council will vote tomorrow on a resolution regarding Alzheimer's and dementia-related diseases.
- The Council intends to adopt conclusions on the issue on 3 December.
- A motion for a resolution to wind up the debate has been tabled under Rule 115(5) of the Rules of Procedure.
- PERSON989 supports the proposed pilot project for joint programming of research activities in the field of neurodegenerative diseases.
- The Commission should consider using Article 182(5) of the Treaty on the Functioning of the European Union as a legal basis for future joint programming initiatives.
- There are more than 7 million Alzheimer's patients in Europe and the number is expected to double in the next decade.
- Medical science still does not fully understand the causes of Alzheimer's disease, but there are promising findings from research.
- Europe needs a more extensive action programme on dementia.


Minuted by: Team Synapse